Paper42418521
A structure-based epitope tagging approach identifies vulnerable sites on the malarial P36-P52 protein complex for antibody-mediated neutralization of Plasmodium sporozoites.
Das S and 9 others. PLoS Pathog, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. A structure-based epitope tagging approach identifies vulnerable sites on the malarial P36-P52 protein complex for antibody-mediated neutralization of Plasmodium sporozoites. Papers, record 42418521. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42418521
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A structure-based epitope tagging approach identifies vulnerable sites on the malarial P36-P52 protein complex for antibody-mediated neutralization of Plasmodium sporozoites.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sporozoites | Major topic |
| Protozoan Proteins | Major topic |
| Malaria | Major topic |
| Antibodies, Protozoan | Major topic |
| Epitopes | Major topic |
| Antibodies, Neutralizing | Major topic |
| Plasmodium berghei | Major topic |
| Animals | |
| Mice | |
| Malaria Vaccines | |
| Humans | |
| Plasmodium |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Agence Nationale de la Recherche | PubMed | |||
| Fondation pour la Recherche Médicale | PubMed | |||
| Conseil Régional d’Ile-de- France | PubMed | |||
| Christian Boulin fellowship | PubMed |
Source PubMed
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35273146 | Improved prediction of protein-protein interactions using AlphaFold2. | Nat Commun | 2022 | https://conductscience.org/library/papers/35273146 | PubMed |
| 2 | 27145334 | Domain Movements upon Activation of Phenylalanine Hydroxylase Characterized by Crystallography and Chromatography-Coupled Small-Angle X-ray Scattering. | J Am Chem Soc | 2016 | https://conductscience.org/library/papers/27145334 | PubMed |
| 3 | 36761022 | Plasmodium sporozoites require the protein B9 to invade hepatocytes. | iScience | 2023 | https://conductscience.org/library/papers/36761022 | PubMed |
| 4 | 19592714 | Structure and flexibility within proteins as identified through small angle X-ray scattering. | Gen Physiol Biophys | 2009 | https://conductscience.org/library/papers/19592714 | PubMed |
| 5 | 32759952 | Improvement of CRISPR/Cas9 system by transfecting Cas9-expressing Plasmodium berghei with linear donor template. | Commun Biol | 2020 | https://conductscience.org/library/papers/32759952 | PubMed |
| 6 | 20507903 | FoXS: a web server for rapid computation and fitting of SAXS profiles. | Nucleic Acids Res | 2010 | https://conductscience.org/library/papers/20507903 | PubMed |
| 7 | 29300836 | CHROMIXS: automatic and interactive analysis of chromatography-coupled small-angle X-ray scattering data. | Bioinformatics | 2018 | https://conductscience.org/library/papers/29300836 | PubMed |
| 8 | 36087586 | Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. | Lancet Infect Dis | 2022 | https://conductscience.org/library/papers/36087586 | PubMed |
| 9 | 36708738 | Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial. | Lancet Infect Dis | 2023 | https://conductscience.org/library/papers/36708738 | PubMed |
| 10 | 27899328 | The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle. | Int J Parasitol | 2017 | https://conductscience.org/library/papers/27899328 | PubMed |
| 11 | 32648541 | Evolutionarily distant I domains can functionally replace the essential ligand-binding domain of Plasmodium TRAP. | Elife | 2020 | https://conductscience.org/library/papers/32648541 | PubMed |
| 12 | 30547015 | The Micronemal Plasmodium Proteins P36 and P52 Act in Concert to Establish the Replication-Permissive Compartment Within Infected Hepatocytes. | Front Cell Infect Microbiol | 2018 | https://conductscience.org/library/papers/30547015 | PubMed |
| 13 | 22990771 | Laboratory maintenance of rodent malaria parasites. | Methods Mol Biol | 2013 | https://conductscience.org/library/papers/22990771 | PubMed |
| 14 | 38656211 | Vaccines and monoclonal antibodies: new tools for malaria control. | Clin Microbiol Rev | 2024 | https://conductscience.org/library/papers/38656211 | PubMed |
| 15 | 33964223 | Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. | Lancet | 2021 | https://conductscience.org/library/papers/33964223 | PubMed |
| 16 | 34293799 | Highly accurate protein structure prediction for the human proteome. | Nature | 2021 | https://conductscience.org/library/papers/34293799 | PubMed |
| 17 | 23325771 | Total and putative surface proteomics of malaria parasite salivary gland sporozoites. | Mol Cell Proteomics | 2013 | https://conductscience.org/library/papers/23325771 | PubMed |
| 18 | 26342424 | Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. | Lancet Infect Dis | 2015 | https://conductscience.org/library/papers/26342424 | PubMed |
| 19 | 35921449 | Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35921449 | PubMed |
| 20 | 16819966 | Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species. | Cell Microbiol | 2006 | https://conductscience.org/library/papers/16819966 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42418521
GET https://conductscience.org/api/papers/v1/42418521/references?page=2